« | »

Should Africans Receive US’s Experimental Ebola Drug?

From the Christian Science Monitor:

Ebola outbreak: Should Africans receive an experimental US drug?

By Noelle Swan | August 7, 2014 

News that two Americans being treated for Ebola in Atlanta are showing signs of improvement after receiving an experimental drug treatment, while at least 900 people diagnosed with the disease in West Africa have died, has raised ethical questions about who should get the drug.

Does the Christian Science Monitor believe in using drugs for any medical condition?

American aid worker Nancy Writebol and US physician Kent Brantly are being treated in a special isolation unit at Emory University Hospital in Atlanta. Both patients are said to be improving after receiving the experimental drug ZMapp. While doctors are hesitant to attribute their progress to the drug, health officials in Africa are eager to get their hands on an even potential treatment.

That’s not what Mr. Obama said. He said (paraphrasing) that the African officials admitted they are too backward to be able to use the Ebola serum. (Because injecting a patient with a serum is very complicated and high tech process.)

“If Americans had this serum all the time, why didn’t they send it to us Africans to help save lives?” Sierra Leone journalist Winston Ojukutu-Macauley asked, according to the Associated Press…

There is, however, a flip side to Mr. Ojukutu-Macauley’s question: Is it ethical for the United States – a nation that has struggled to overcome a history of murky ethics around testing drugs on African-Americans – to send an experimental drug to Africa that it hasn’t tested on its own citizens?

Oh boy, we had somehow forgotten about our ‘murky history’ of testing drugs on blacks.

But this is a textbook case of being ‘damned if we do, and damned if we don’t.’ If we send the serum, we are using Africans as guinea pigs. Withhold it, and we are committing genocide. Either way, we are racists.

Traditionally, drugs in the US undergo a rigorous approval process involving multiple efficacy and toxicity studies in animals before they are tested on humans, as mandated by the US Food and Drug Administration. The drug ZMapp has been tested on monkeys – with a 43 percent success rate, according to the manufacturer – but has never before been given to humans.

The Centers for Disease Control and Prevention’s decision to allow Ms. Writebol and Dr. Brantly to grant consent to experimental treatment before that process has been fully completed is extremely unusual. Even if they recover fully, two patients is hardly a statistically significant study group. Just because they don’t have a negative reaction to the drug doesn’t mean that others won’t, medical experts say…

ZMapp is produced by Mapp Biopharmaceutical Inc. of San Diego. ZMapp contains three antibodies believed to boost the immune system’s ability to fend off the virus. Scientists originally culled the antibodies from field mice that demonstrated resistance to the disease, and now grow them in tobacco plants. According to the manufacturer, the process is “painfully slow,” and production of even “a modest amount” could take two to three months…

Why should we believe ‘Big Pharma’? They are probably just trying to keep the price high.

This article was posted by Steve Gilbert on Friday, August 8th, 2014. Comments are currently closed.

One Response to “Should Africans Receive US’s Experimental Ebola Drug?”

  1. I’ve read Jimmy Carter’s Global 2000. At the Carter center in Atlanta. What he and Kissinger and the rest of the Satanic Elite want is depopulation so .. make up your own mind which way this is going to go ..




« Front Page | To Top
« | »